Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Janicek

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancer|July 15, 1994
Ovarian carcinoma. A review of the significance of familial risk factors and the role of prophylactic oophorectomy in cancer preventionH N Nguyen, H E Averette, M Janicek
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding pilot studyM A Shipp, D Neuberg, M Janicek, et al.
Cancer|December 24, 1997
Tumor angiogenesis as a prognostic factor in ovarian carcinoma: quantification of endothelial immunoreactivity by image analysisW M Schoell, D Pieber, O Reich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapyM Janicek, W Kaplan, D Neuberg, et al.
Gynecologic Oncology|May 8, 1998
Close vaginal margins as a prognostic factor after radical hysterectomyR E Estape, R Angioli, M Madrigal, et al.
Oncology Reports|May 19, 2011
Advanced mucinous adenocarcinoma in pregnancyR Angioli, S Yasin, R Estape, et al.
International Journal of Oncology|April 30, 2011
Use of lonidamine to potentiate the effect of cisplatin and carboplatin on platinum resistant human ovarian cancer cellsR Angioli, M Janicek, B Sevin, et al.
Cancer Investigation|December 11, 1999
Monitoring therapeutic response in skeletal metastases using dual-energy x-ray absorptiometry: a prospective feasibility study in breast cancer patientsC L Shapiro, J Keating, J E Angell, et al.
Gynecologic Oncology|March 26, 1998
Significance of intraperitoneal cytology in patients undergoing radical hysterectomyR Estape, R Angioli, F Wagman, et al.
Investigative Radiology|May 1, 1990
Atherosclerosis, peripheral arterial disease and the vascular response to ketanserinM Janicek, C J Grassi, M Meyerovitz, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer|July 15, 1994
Ovarian carcinoma. A review of the significance of familial risk factors and the role of prophylactic oophorectomy in cancer preventionH N Nguyen, H E Averette, M Janicek
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding pilot studyM A Shipp, D Neuberg, M Janicek, et al.
Cancer|December 24, 1997
Tumor angiogenesis as a prognostic factor in ovarian carcinoma: quantification of endothelial immunoreactivity by image analysisW M Schoell, D Pieber, O Reich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapyM Janicek, W Kaplan, D Neuberg, et al.
Gynecologic Oncology|May 8, 1998
Close vaginal margins as a prognostic factor after radical hysterectomyR E Estape, R Angioli, M Madrigal, et al.
Oncology Reports|May 19, 2011
Advanced mucinous adenocarcinoma in pregnancyR Angioli, S Yasin, R Estape, et al.
International Journal of Oncology|April 30, 2011
Use of lonidamine to potentiate the effect of cisplatin and carboplatin on platinum resistant human ovarian cancer cellsR Angioli, M Janicek, B Sevin, et al.
Cancer Investigation|December 11, 1999
Monitoring therapeutic response in skeletal metastases using dual-energy x-ray absorptiometry: a prospective feasibility study in breast cancer patientsC L Shapiro, J Keating, J E Angell, et al.
Gynecologic Oncology|March 26, 1998
Significance of intraperitoneal cytology in patients undergoing radical hysterectomyR Estape, R Angioli, F Wagman, et al.
Investigative Radiology|May 1, 1990
Atherosclerosis, peripheral arterial disease and the vascular response to ketanserinM Janicek, C J Grassi, M Meyerovitz, et al.
Pageof 1